The Enterprise Value as of December 2024 (TTM) for Capricor Therapeutics, Inc. (CAPR) is 575.76M

According to Capricor Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 575.76M. This represents a change of 143.84% compared to the average of 236.12M of the last 4 quarters.

Capricor Therapeutics, Inc. (CAPR) Historical Enterprise Value (quarterly & annually)

How has CAPR Enterprise Value performed in the past?

The mean historical Enterprise Value of Capricor Therapeutics, Inc. over the last ten years is 44.07M. The current 575.76M Enterprise Value has changed 130.56% with respect to the historical average. Over the past ten years (40 quarters), CAPR's Enterprise Value was at its highest in in the September 2024 quarter at 436.57M. The Enterprise Value was at its lowest in in the June 2023 quarter at -7490432065.24.

Capricor Therapeutics, Inc. (CAPR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Capricor Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Capricor Therapeutics, Inc. (CAPR) Average Enterprise Value

How has CAPR Enterprise Value performed in the past?

The current Enterprise Value of Capricor Therapeutics, Inc. (CAPR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Capricor Therapeutics, Inc. (CAPR) Enterprise Value vs. Peers

How is CAPR’s Enterprise Value compared to its peers?

Capricor Therapeutics, Inc.’s Enterprise Value is greater than Bio-Path Holdings, Inc. (4.24M), less than Catalyst Biosciences, Inc. (1.03B), greater than Diffusion Pharmaceuticals Inc. (10.50M), greater than NextCure, Inc. (4.04M), greater than Pulmatrix, Inc. (10.26M), greater than Akari Therapeutics, Plc (10.29M), less than Soleno Therapeutics, Inc. (1.89B), greater than Unicycive Therapeutics, Inc. (37.28M), greater than Cidara Therapeutics, Inc. (41.45M), greater than Phio Pharmaceuticals Corp. (-3036859.00), greater than Onconova Therapeutics, Inc. (32.62M), greater than Moleculin Biotech, Inc. (-3378743.00), less than IDEAYA Biosciences, Inc. (1.81B), greater than AnaptysBio, Inc. (250.00M), greater than MeiraGTx Holdings plc (439.82M), greater than Keros Therapeutics, Inc. (182.09M), greater than Homology Medicines, Inc. (-103303255.00),

Build a custom stock screener for Capricor Therapeutics, Inc. (CAPR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Capricor Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Capricor Therapeutics, Inc. (CAPR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Capricor Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.